IRS2 has been suggested as an oncogene in CRC,9 and IRS2 copy number gain has been shown to predict the sensitivity of CRC cells to an IGF-1R/IR inhibitor.21 Consistent with previous studies, we observed a broad involvement of IRS2 in promoting aggressive behavior among CRC cells. This evidence concerns the gene IRS2 and colorectal carcinoma.